Bioventix PLC (AIM: BVXP)
Health Care · Biotechnology · GB
£17.50
0.00% today · -27.1% 1Y
Bioventix PLC (AIM: BVXP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $120.83M.
Over the last twelve months the share price has lost 27.1%, trading between 13.00 and 25.00.
Tweenvest scores Bioventix PLC across four factors: quality 97/100, value 80/100, growth 26/100, dividend 81/100. Its strongest factor is quality.
BVXP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $120.83M
- Revenue (TTM)
- $16.88M
- P/E
- 12.45
- EPS
- 1.41
- Dividend yield
- 8.57%
- Beta (5Y)
- 0.54
- 52-week high
- £25.00
- 52-week low
- £13.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.22M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Heidelberg Pharma AGXTRA: HPHA | $123.74M | €2.35 | -8.91% |
| StemCyte International, Ltd.TWSE: 4178 | $121.98M | NT$18.00 | +9.09% |
| TuHURA Biosciences, Inc.NasdaqCM: HURA | $121.72M | $1.93 | +1.05% |
| Pharmosa Biopharm Inc.TPEX: 6875 | $121.25M | NT$29.90 | -6.12% |
| Quantum Cyber N.V.NasdaqCM: QUCY | $120.22M | $1.39 | -2.80% |
| Foghorn Therapeutics Inc.NasdaqGM: FHTX | $119.96M | $1.99 | -1.49% |
| Inovio Pharmaceuticals, Inc.NasdaqCM: INO | $119.42M | $1.09 | -5.63% |
| Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP | $118.56M | $5.27 | -14.03% |
Figures last refreshed Oct 4, 2026.